BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.

BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical medical devices.

Avery Dennison, in partnership with Turck Vilant Systems & Becton, Dickinson and Company, introduces BD iDFill Individual ...

Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...

Invent.ai is working with Alo Yoga, a luxury activewear brand, to transform the retailers inventory planning and ...

Avery Dennison has announced its plans for Pharmapack 2025, which includes showcasing a groundbreaking RFID (radio frequency identification) pre-filled syringe (PFS) authentication solution. Branded ...

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.

Learn more about whether Becton, Dickinson and Company or Intuitive Surgical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

As part of the company's 2024 investment of more than $10 million to expand manufacturing capacity, new needle and syringe production lines have been installed at the BD plants in Connecticut and ...

As part of the company’s 2024 investment of more than $10M to expand manufacturing capacity, new needle and syringe production lines have been installed at the BD plants in Connecticut and Nebraska.